Outline in brief the main aim of safety pharmacology, and the differences between safety predictions driven by in vitro mechanistic profiling vs in vivo toxicity pre-clinical testing
• Outline in brief the main aim of safety pharmacology, and the differences between safety predictions driven by in vitro mechanistic profiling vs in vivo toxicity pre-clinical testing (e.g. describe strengths and limitations of each approach). • Present the data from the analysis, appropriately labelled with descriptive legends and some descriptive text. • The modulation […]